Annual Accounts Payable
$15.26 M
-$7.16 M-31.93%
31 December 2023
Summary:
Sangamo Therapeutics annual accounts payable is currently $15.26 million, with the most recent change of -$7.16 million (-31.93%) on 31 December 2023. During the last 3 years, it has risen by +$2.71 million (+21.56%). SGMO annual accounts payable is now -31.93% below its all-time high of $22.42 million, reached on 31 December 2022.SGMO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$19.79 M
+$2.20 M+12.51%
30 September 2024
Summary:
Sangamo Therapeutics quarterly accounts payable is currently $19.79 million, with the most recent change of +$2.20 million (+12.51%) on 30 September 2024. Over the past year, it has increased by +$4.33 million (+28.04%). SGMO quarterly accounts payable is now -11.72% below its all-time high of $22.42 million, reached on 31 December 2022.SGMO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.9% | +28.0% |
| 3 y3 years | +21.6% | +147.9% |
| 5 y5 years | +354.8% | - |
SGMO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -31.9% | +56.4% | -11.7% | +147.9% |
| 5 y | 5 years | -31.9% | +354.8% | -11.7% | +196.7% |
| alltime | all time | -31.9% | >+9999.0% | -11.7% | >+9999.0% |
Sangamo Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.79 M(+12.5%) |
| June 2024 | - | $17.59 M(+13.7%) |
| Mar 2024 | - | $15.47 M(+1.4%) |
| Dec 2023 | $15.26 M(-31.9%) | $15.26 M(-1.3%) |
| Sept 2023 | - | $15.46 M(+4.2%) |
| June 2023 | - | $14.84 M(-25.5%) |
| Mar 2023 | - | $19.92 M(-11.1%) |
| Dec 2022 | $22.42 M(+129.7%) | $22.42 M(+29.0%) |
| Sept 2022 | - | $17.38 M(+32.9%) |
| June 2022 | - | $13.08 M(+17.3%) |
| Mar 2022 | - | $11.15 M(+14.2%) |
| Dec 2021 | $9.76 M(-22.3%) | $9.76 M(+22.3%) |
| Sept 2021 | - | $7.98 M(-21.2%) |
| June 2021 | - | $10.13 M(-12.9%) |
| Mar 2021 | - | $11.64 M(-7.3%) |
| Dec 2020 | $12.55 M(+88.2%) | $12.55 M(+88.2%) |
| Dec 2019 | $6.67 M(+98.8%) | $6.67 M(+98.8%) |
| Dec 2018 | $3.35 M(>+9900.0%) | $3.35 M(>+9900.0%) |
| Dec 2017 | $16.00 K(-99.4%) | $16.00 K(-99.4%) |
| Dec 2016 | $2.58 M(-33.9%) | $2.58 M(-33.9%) |
| Dec 2015 | $3.90 M(-29.3%) | $3.90 M(-29.3%) |
| Dec 2014 | $5.53 M(+82.8%) | $5.53 M(+82.8%) |
| Dec 2013 | $3.02 M(-0.8%) | $3.02 M(-0.8%) |
| Dec 2012 | $3.05 M(-25.9%) | $3.05 M(-25.9%) |
| Dec 2011 | $4.11 M(+16.2%) | $4.11 M(+16.2%) |
| Dec 2010 | $3.54 M(+127.6%) | $3.54 M(+9.1%) |
| Sept 2008 | - | $3.24 M(+24.2%) |
| June 2008 | - | $2.61 M(-36.5%) |
| Mar 2008 | - | $4.11 M(+164.6%) |
| Dec 2007 | $1.55 M | $1.55 M(-15.1%) |
| Sept 2007 | - | $1.83 M(-33.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2007 | - | $2.77 M(+80.9%) |
| Mar 2007 | - | $1.53 M(+38.1%) |
| Dec 2006 | $1.11 M(-27.8%) | $1.11 M(-4.2%) |
| Sept 2006 | - | $1.16 M(+21.3%) |
| June 2006 | - | $953.00 K(+20.0%) |
| Mar 2006 | - | $794.00 K(-48.2%) |
| Dec 2005 | $1.53 M(+69.3%) | $1.53 M(+69.1%) |
| Sept 2005 | - | $907.00 K(+96.3%) |
| June 2005 | - | $462.00 K(-26.4%) |
| Mar 2005 | - | $628.00 K(-30.7%) |
| Dec 2004 | $906.00 K(+11.2%) | $906.00 K(+22.6%) |
| Sept 2004 | - | $739.00 K(+41.6%) |
| June 2004 | - | $522.00 K(+24.9%) |
| Mar 2004 | - | $418.00 K(-48.7%) |
| Dec 2003 | $815.00 K(-13.0%) | $815.00 K(-36.8%) |
| Sept 2003 | - | $1.29 M(+35.1%) |
| June 2003 | - | $955.00 K(+93.3%) |
| Mar 2003 | - | $494.00 K(-47.3%) |
| Dec 2002 | $937.00 K(-25.7%) | $937.00 K(+55.4%) |
| Sept 2002 | - | $603.00 K(+11.5%) |
| June 2002 | - | $541.00 K(-42.4%) |
| Mar 2002 | - | $939.00 K(-25.5%) |
| Dec 2001 | $1.26 M(+98.9%) | $1.26 M(+58.0%) |
| Sept 2001 | - | $798.00 K(+331.4%) |
| June 2001 | - | $185.00 K(-26.0%) |
| Mar 2001 | - | $250.00 K(-60.6%) |
| Dec 2000 | $634.00 K(+111.3%) | $634.00 K(+395.3%) |
| Sept 2000 | - | $128.00 K(+236.8%) |
| June 2000 | - | $38.00 K(-66.1%) |
| Mar 2000 | - | $112.00 K |
| Dec 1999 | $300.00 K | - |
FAQ
- What is Sangamo Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual accounts payable year-on-year change?
- What is Sangamo Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly accounts payable year-on-year change?
What is Sangamo Therapeutics annual accounts payable?
The current annual accounts payable of SGMO is $15.26 M
What is the all time high annual accounts payable for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual accounts payable is $22.42 M
What is Sangamo Therapeutics annual accounts payable year-on-year change?
Over the past year, SGMO annual accounts payable has changed by -$7.16 M (-31.93%)
What is Sangamo Therapeutics quarterly accounts payable?
The current quarterly accounts payable of SGMO is $19.79 M
What is the all time high quarterly accounts payable for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly accounts payable is $22.42 M
What is Sangamo Therapeutics quarterly accounts payable year-on-year change?
Over the past year, SGMO quarterly accounts payable has changed by +$4.33 M (+28.04%)